Hemoconcentration is associated with early faster fluid rate and increased risk of persistent organ failure in acute pancreatitis patients
T Jin, L Li, L Deng, S Wen, R Zhang, N Shi, P Zhu… - JGH …, 2020 - Wiley Online Library
Background Controversies existed surrounding the use of hematocrit to guide early fluid
therapy in acute pancreatitis (AP). The association between hematocrit, early fluid therapy …
therapy in acute pancreatitis (AP). The association between hematocrit, early fluid therapy …
Hemoconcentration is associated with early faster fluid rate and increased risk of persistent organ failure in acute pancreatitis patients.
T Jin, L Li, L Deng, S Wen, R Zhang, N Shi, P Zhu… - 2020 - researchspace.auckland.ac.nz
Background Controversies existed surrounding the use of hematocrit to guide early fluid
therapy in acute pancreatitis (AP). The association between hematocrit, early fluid therapy …
therapy in acute pancreatitis (AP). The association between hematocrit, early fluid therapy …
Hemoconcentration is associated with early faster fluid rate and increased risk of persistent organ failure in acute pancreatitis patients.
T Jin, L Li, L Deng, S Wen, R Zhang, N Shi… - JGH Open: an Open …, 2020 - europepmc.org
Background Controversies existed surrounding the use of hematocrit to guide early fluid
therapy in acute pancreatitis (AP). The association between hematocrit, early fluid therapy …
therapy in acute pancreatitis (AP). The association between hematocrit, early fluid therapy …
[PDF][PDF] Hemoconcentration is associated with early faster fluid rate and increased risk of persistent organ failure in acute pancreatitis patients
T Jin, L Li, L Deng, S Wen, R Zhang, N Shi, P Zhu… - 2020 - core.ac.uk
Background: Controversies existed surrounding the use of hematocrit to guide early fluid
therapy in acute pancreatitis (AP). The association between hematocrit, early fluid therapy …
therapy in acute pancreatitis (AP). The association between hematocrit, early fluid therapy …
Hemoconcentration is associated with early faster fluid rate and increased risk of persistent organ failure in acute pancreatitis patients
T Jin, L Li, L Deng, S Wen, R Zhang, N Shi, P Zhu… - JGH …, 2020 - search.proquest.com
Background Controversies existed surrounding the use of hematocrit to guide early fluid
therapy in acute pancreatitis (AP). The association between hematocrit, early fluid therapy …
therapy in acute pancreatitis (AP). The association between hematocrit, early fluid therapy …
Hemoconcentration is associated with early faster fluid rate and increased risk of persistent organ failure in acute pancreatitis patients
T Jin, L Li, L Deng, S Wen, R Zhang, N Shi… - JGH …, 2020 - pure.johnshopkins.edu
Background: Controversies existed surrounding the use of hematocrit to guide early fluid
therapy in acute pancreatitis (AP). The association between hematocrit, early fluid therapy …
therapy in acute pancreatitis (AP). The association between hematocrit, early fluid therapy …
Hemoconcentration is associated with early faster fluid rate and increased risk of persistent organ failure in acute pancreatitis patients
T Jin, L Li, L Deng, S Wen, R Zhang… - JGH open: an …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Controversies existed surrounding the use of hematocrit to guide early fluid
therapy in acute pancreatitis (AP). The association between hematocrit, early fluid therapy …
therapy in acute pancreatitis (AP). The association between hematocrit, early fluid therapy …
[HTML][HTML] Hemoconcentration is associated with early faster fluid rate and increased risk of persistent organ failure in acute pancreatitis patients
T Jin, L Li, L Deng, S Wen, R Zhang, N Shi… - JGH Open: An Open …, 2020 - ncbi.nlm.nih.gov
Background Controversies existed surrounding the use of hematocrit to guide early fluid
therapy in acute pancreatitis (AP). The association between hematocrit, early fluid therapy …
therapy in acute pancreatitis (AP). The association between hematocrit, early fluid therapy …